1
Anwar A Hussain: Method of administering narcotic antagonists and analgesics and novel dosage forms containing same. University of Kentucky Research Foundation, Burns Doane Swecker & Mathis, August 7, 1984: US04464378 (197 worldwide citation)

The invention provides a novel method of administering narcotic antagonists, narcotic analgesics and related compounds, and novel dosage forms containing those compounds which are adapted for nasal administration. The nasal dosage forms disclosed include solutions, suspensions, gels and ointments. E ...


2
Anwar A Hussain, Takeru Higuchi, John W Shell: Bioerodible ocular device. Alza Corporation, Thomas E Ciotti, Paul L Sabatine, Edward L Mandell, June 1, 1976: US03960150 (100 worldwide citation)

An ocular insert for the continuous controlled administration of a predetermined therapeutically effective dosage of drug to the eye over a prolonged period of time. The device meters the flow of drug by means of a drug release rate controlling material. The insert bioerodes in the environment of th ...


3
Nicolae S Bodor, Kenneth B Sloan, Anwar A Hussain: Novel, transient pro-drug forms of L-DOPA to treat Parkinsons disease. Interx Research Corporation, Charles N Blitzer, July 12, 1977: US04035507 (82 worldwide citation)

There is provided, novel, transient pro-drug forms of L-DOPA (3,4-dihydroxy-L-phenylalanine), having the formula: ##STR1## wherein R represents a hydrogen atom, an acyl group, ##STR2## group, a -CO-pyridyl group, and a -CO-R.sub.3 group, wherein R.sub.3 represents the residue of any N,N-C.sub.1 -C.s ...


4

5
Takeru Higuchi, Anwar A Hussain, John W Shell: Bioerodible ocular device. Alza Corporation, Thomas E Ciotti, Paul L Sabatine, Edward L Mandell, October 19, 1976: US03986510 (71 worldwide citation)

An ocular insert for the continuous controlled administration of a predetermined therapeutically effective dosage of drug to the eye over a prolonged period of time. The device meters the flow of drug by means of a drug release rate controlling material. The insert bioerodes in the environment of th ...


6
Takeru Higuchi, Anwar A Hussain, John W Shell: Ocular insert. Alza Corporation, Thomas E Ciotti, Paul L Sabatine, Edward L Mandell, December 7, 1976: US03995635 (62 worldwide citation)

A drug-dispensing ocular insert containing a drug and suited for application to the eyeball to dispense said drug to the eye over a prolonged period of time, includes, for permitting facile insertion into and comfortable retention within the eye, and more importantly for preventing the accidental ex ...


7
Anwar A Hussain, Shinichiro Hirai, Rima Bawarshi: Nasal dosage forms containing natural female sex hormones. University of Kentucky Research Foundation, Burns Doane Swecker & Mathis, May 17, 1983: US04383993 (55 worldwide citation)

The invention relates to a novel method of administering the natural female sex hormones, 17 .beta.-estradiol and progesterone, to achieve enhanced bioavailability thereof. The invention further relates to novel dosage forms of 17 .beta.-estradiol and/or progesterone which are adapted for nasal admi ...


8
Takeru Higuchi, Anwar A Hussain, John W Shell: Bioerodible ocular device. Alza Corporation, Thomas E Ciotti, Paul L Sabatine, Edward L Mandell, November 23, 1976: US03993071 (52 worldwide citation)

An ocular insert for the continuous controlled administration of a predetermined therapeutically effective dosage of drug to the eye over a prolonged period of time. The device meters the flow of drug by means of a drug release rate controlling material. The insert bioerodes in the environment of th ...


9
Anwar A Hussain, Shinichiro Hirai, Rima Bawarshi: Method of administering natural female sex hormones. University of Kentucky Research Foundation, Burns Doane Swecker & Mathis, February 16, 1982: US04315925 (45 worldwide citation)

The invention relates to a novel method of administering the natural female sex hormones, 17 .beta.- estradiol and progesterone, to achieve enhanced bioavailability thereof. The invention further relates to novel dosage forms of 17 .beta.- estradiol and/or progesterone which are adapted for nasal ad ...


10
Takeru Higuchi, Anwar A Hussain, John W Shell: Bioerodible ocular device. Alza Corporation, Thomas E Ciotti, Paul L Sabatine, Edward L Mandell, September 21, 1976: US03981303 (34 worldwide citation)

An ocular insert for the continuous controlled administration of a predetermined therapeutically effective dosage of drug to the eye over a prolonged period of time. The device meters the flow of drug by means of a drug release rate controlling material. The insert bioerodes in the environment of th ...